Los Angeles Capital Management’s PMV Pharmaceuticals PMVP Stock Holding History

Los Angeles Capital Management’s Portfolio PMVP Stock Details PMVP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-44,832	Closed	-$275K	–	1214
2023 Q3	$275K	Sell	44,832 -17,698	-28%	-$122K	﹤0.01%	985
2023 Q2	$391K	Buy	62,530 +12,473	+25%	+$65.4K	﹤0.01%	930
2023 Q1	$239K	Sell	50,057 -913	-2%	-$6.42K	﹤0.01%	1084
2022 Q4	$443K	Buy	50,970 +19,180	+60%	+$204K	﹤0.01%	928
2022 Q3	$378K	Buy	31,790 +320	+1%	+$4.62K	﹤0.01%	1006
2022 Q2	$448K	Buy	31,470 +12,020	+62%	+$175K	﹤0.01%	1006
2022 Q1	$405K	Buy	19,450 +6,900	+55%	+$122K	﹤0.01%	1119
2021 Q4	$290K	Hold	12,550	–	–	﹤0.01%	1250
2021 Q3	$374K	Buy	+12,550	New	+$401K	﹤0.01%	1196

Other funds holding PMVP

OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

ACH

ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return

Euclidean Capital New York $392M AUM 31.85% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Alkeon Capital Management New York $59.5B AUM 51.63% 1-Year Est. Return

Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return

Verition Fund Management Greenwich, Connecticut $15.4B AUM 30.69% 1-Year Est. Return

PHS

PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return

Los Angeles Capital Management's PMVP Position: Q4 2023 in Review

Los Angeles Capital Management sold out of PMV Pharmaceuticals (PMVP) in Q4 2023, closing a stake of 44,832 shares — an estimated $275K sold.

Los Angeles Capital Management first reported a position in PMVP in Q3 2021 and held it in 9 quarters. The position peaked at $448K in Q2 2022. 98 funds tracked by Wall St. Rank hold PMVP as of Q4 2023.

Los Angeles Capital Management reported no remaining PMV Pharmaceuticals position as of Q4 2023 after selling out during the quarter.
Los Angeles Capital Management sold 44,832 PMV Pharmaceuticals shares in Q4 2023, an estimated $275K.
Los Angeles Capital Management first reported a position in PMV Pharmaceuticals in Q3 2021 and held it in 9 quarters.
Los Angeles Capital Management's PMV Pharmaceuticals position peaked at $448K in Q2 2022.
98 funds tracked by Wall St. Rank held PMV Pharmaceuticals as of Q4 2023.

Based on Los Angeles Capital Management's 13F filing for Q4 2023, filed 6 Feb 2024.